Sharbat et al v. Iovance Biotherapeutics, Inc. et al
Filing
246
JUDGMENT It is hereby ORDERED, ADJUDGED AND DECREED that defendant Iovance Biotherapeutics, Inc. f/k/a Lion Biotechnologies, Inc. f/k/a Genesis Biopharma, Inc. shall recover from plaintiffs Solomon Sharbat, Solomon Capital LLC, Solomon Capital 401 (k) Trust, and Shelhav Raff, jointly and severally, the amount of six hundred forty nine thousand nine hundred thirty nine dollars and twenty cents ($649,939.20). (Signed by Judge Edgardo Ramos on 9/23/2024) (jca) Transmission to Finance Unit (Cashiers) for processing.
<![CDATA[
UNITED STATES DISTRICT COURT
SOUTHERN DISTRICT OF NEW YORK
SOLOMON SHARBAT, SOLOMON CAPITAL LLC,
SOLOMON CAPITAL 401(K) TRUST, SHELHAV RAFF,
PLAINTIFFS,
CIVIL ACTION NO: 1:20-CV-01391
V.
IOVANCE BIOTHERAPEUTICS, INC., F/K/A LION
BIOTECHNOLOGIES INC. F/K/A GENESIS BIOPHARMA,
INC., AND MANISH SINGH,
JUDGMENT
DEFENDANTS.
It is hereby ORDERED, ADJUDGED AND DECREED that defendant Iovance
Biotherapeutics, Inc. f/k/a Lion Biotechnologies, Inc. f/k/a Genesis Biopharma, Inc. shall recover
from plaintiffs Solomon Sharbat, Solomon Capital LLC, Solomon Capital 401(k) Trust, and
Shelhav Raff, jointly and severally, the amount of six hundred forty nine thousand nine hundred
thirty nine dollars and twenty cents ($649,939.20).
Dated:
September 23, 2024
HON. EDGARDO RAMOS
Edgardo Ramos, U.S.D.J.
03424-0008 4874-0353-0727.1
]]>
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?
